Magnitude Biosciences secures over £700,000 to accelerate in vivo high-throughput drug discovery platform
Posted on the 27 May 2025Magnitude Biosciences, a specialist contract research organisation (CRO) in County Durham offering in vivo discovery of treatments for age-related conditions and other diseases using C. elegans, has secured over £700,000 in combined funding to scale up its high-throughput screening (HTS) platform.